Transarterial chemoembolization with medium-sized doxorubicin-eluting Callisphere is safe and effective for patients with hepatocellular carcinoma

Scientific Reports
Cao-Ye WangQi Wang

Abstract

The study aimed to compare the tumor response to and complications of doxorubicin-eluting CalliSphere bead-transarterial chemoembolization (DEB-TACE) using small- and medium-sized beads in patients with hepatocellular carcinoma (HCC) who underwent multiple rounds of oncology therapies. Sixty patients with intermediate stage HCC who had previously received multiple oncology therapies underwent DEB-TACE with CalliSpheres of 100-300 μm (small bead group, n = 34) or 300-500 μm (medium bead group, n = 26) in diameter between October 2016 and December 2018. Adverse events and the response rate of the index tumor based on the modified Response Evaluation Criteria in Solid Tumors at 3 months post-TACE were compared between the groups. The rates of complete response, partial response, stable disease, and progressive disease were 35.4%, 29.4%, 17.6%, and 17.6%, respectively, for the small bead group and 33.1%, 23.1%, 20.8%, and 23.0%, respectively, for the medium bead group, showing no significant between-group differences (P > 0.05). Common Terminology Criteria for Adverse Events version 4.0 grade 3/4 adverse events were reported in 8 patients in the small bead group and in no patients in the medium bead group, showing a significant gro...Continue Reading

References

Apr 20, 2006·European Journal of Radiology·Jinglin XiaBinghui Yang
Aug 8, 2006·Gastroenterology·Kenichi TakayasuUNKNOWN Liver Cancer Study Group of Japan
May 2, 2009·Journal of the National Comprehensive Cancer Network : JNCCN·Al B BensonAndrew X Zhu
Nov 13, 2009·Cardiovascular and Interventional Radiology·Johannes LammerUNKNOWN PRECISION V Investigators
Oct 20, 2011·Cardiovascular and Interventional Radiology·Riccardo LencioniJean-Francois H Geschwind
Mar 20, 2012·Journal of Hepatology·UNKNOWN European Association For The Study Of The Liver, UNKNOWN European Organisation For Research And Treatment Of Cancer
Feb 6, 2013·Journal of Vascular and Interventional Radiology : JVIR·Siddharth A PadiaMatthew J Kogut
Apr 23, 2013·Journal of Vascular and Interventional Radiology : JVIR·Saebeom HurWoo Ho Kim
Mar 4, 2014·Journal of Vascular and Interventional Radiology : JVIR·Riccardo LencioniRobert C G Martin
May 31, 2014·Cardiovascular and Interventional Radiology·Julien JoskinFrédéric Deschamps
Feb 24, 2015·Journal of Vascular and Interventional Radiology : JVIR·Amy R DeipolyiSuvranu Ganguli
May 17, 2015·Journal of Vascular and Interventional Radiology : JVIR·Bruno C OdisioAlda L Tam
Mar 12, 2016·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Antonio FacciorussoNicola Muscatiello
Oct 19, 2016·Journal of Digestive Diseases·Jing Huai ZouSheng Long Ye

❮ Previous
Next ❯

Software Mentioned

CalliSpheres
SPSS
mRECIST

Related Concepts

Related Feeds

Adrenocortical Carcinoma

Hepatocellular carcinoma is the most common type of primary liver cancer and frequently occurs in individuals with chronic liver diseases like cirrhosis. Here is the latest research.